VERA

Vera Therapeutics, Inc. - Class A Common Stock (VERA)

About Vera Therapeutics, Inc. - Class A Common Stock (VERA)

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Details

Daily high

$35.29

Daily low

$33.75

Price at open

$33.91

52 Week High

$56.05

52 Week Low

$22.72

Market cap

2.5B

Dividend yield

Volume

3.8M

Avg. volume

1.9M

P/E ratio

-5.97

Vera Therapeutics, Inc. - Class A Common Stock News